Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Network.
Press releases published on April 30, 2025
Bitget Wallet Launches Swap API Program, Partners with Morph’s DEX BulbaSwap as Pilot Integration
GlobeNewswire
·
April 30, 2025
SAN SALVADOR, El Salvador, April 30, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, a leading non-custodial Web3 wallet, has launched its Swap API Program, officially opening access to its Swap functionality for third-party decentralized exchanges (DEXs). The …
ibex to Showcase AI-powered CX Solutions for Utilities at the IUCX Annual Conference 2025
GlobeNewswire
·
April 30, 2025
PHOENIX, April 30, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it will be participating in the IUCX (Innovate UtilityCX) Annual …
Backstage IDO Pre-registration Now Open on RWA Investor Platform
GlobeNewswire
·
April 30, 2025
ROAD TOWN, British Virgin Islands, April 30, 2025 (GLOBE NEWSWIRE) -- Backstage, a decentralized ecosystem revolutionizing the $1.3 trillion global events industry, has opened pre-registration for its Initial DEX Offering (IDO) on the RWA Investor Platform …
Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
GlobeNewswire
·
April 30, 2025
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironment (TME) IL-13Rα2 is overexpressed by some of the most “ …
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
GlobeNewswire
·
April 30, 2025
– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that is often underdiagnosed or …
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 30, 2025
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced …
Jet.AI and Consensus Core Announce Plans for Multi-Billion Dollar (1.5 GW) AI Data Center Joint Venture in Canada
GlobeNewswire
·
April 30, 2025
LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), a company transitioning to a pure-play artificial-intelligence (“AI”) data-center enterprise, announced the signing of a Letter of Intent (“LOI”) to form …
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
GlobeNewswire
·
April 30, 2025
— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage biopharmaceutical company focused on …
Integral Metals Reports Preliminary Geomicrobial Results from Burntwood Project, Highlights Biological Pathfinder Potential for REE Exploration
GlobeNewswire
·
April 30, 2025
CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce preliminary results from its 2024 geomicrobial survey at the Burntwood Project in northern …
Global Uranium Advances Athabasca Basin Exploration with Launch of ZTEM Survey at Astro Project
GlobeNewswire
·
April 30, 2025
CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the "Company" or “Global”) and Cosa Resources Corp. (TSX-V: COSA) (OTCQB: COSAF) (FSE: SSKU) (“Cosa”) are pleased to announce that geophysical …
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
GlobeNewswire
·
April 30, 2025
- Topline data expected in mid-2025 - SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation oral norovirus …
Banco Santander-Chile Announces First Quarter 2025 Earnings
GlobeNewswire
·
April 30, 2025
SANTIAGO, Chile, April 30, 2025 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the three-month period ended March 31, 2025, and first quarter 2025 (1Q25). Solid financial performance with a ROAE2 of …
Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results
GlobeNewswire
·
April 30, 2025
Hamilton, Bermuda, April 30, 2025 (GLOBE NEWSWIRE) -- Management to host conference call today, April 30, at 8:00 a.m. EDT RNA delivery business progressing with platform development, new applications and collaborations Plans to partially spin off RNA …
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
GlobeNewswire
·
April 30, 2025
Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin Data supports ongoing Phase 1 clinical trial for CT-95 PHILADELPHIA, April 30, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ …
Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire
·
April 30, 2025
ASHBURN, Va., April 30, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on the development and commercialization of therapeutic products that …
Altimmune to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
GAITHERSBURG, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Citizens Life …
Stallion Uranium Announces Completion of Ground Gravity Survey over Coyote Target
GlobeNewswire
·
April 30, 2025
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the successful completion of a ground gravity survey over its Coyote Target, …
InflaRx to Report First Quarter 2025 Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
JENA, Germany, April 30, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it will report its first quarter 2025 financial …
Brookfield Infrastructure Reports Solid First Quarter 2025 Results
GlobeNewswire
·
April 30, 2025
BROOKFIELD, News, April 30, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the first quarter ended March 31, 2025. “We delivered …
BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire
·
April 30, 2025
RESEARCH TRIANGLE PARK, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Citizens Life Sciences Conference in New York on Thursday, May 8, …